EP Patent

EP3725536A1 — Security document with double verification lenses

Assigned to Thales DIS France SA · Expires 2020-10-21 · 6y expired

What this patent protects

A multipage security document has a first verification lens located in a see-through portion and corresponding to a first verification feature and a second verification lens collocated with the first verification lens as an adjacent layer to the first verification lens in the see…

USPTO Abstract

A multipage security document has a first verification lens located in a see-through portion and corresponding to a first verification feature and a second verification lens collocated with the first verification lens as an adjacent layer to the first verification lens in the see-through portion and corresponding to a second verification feature.

Drugs covered by this patent

Patent Metadata

Patent number
EP3725536A1
Jurisdiction
EP
Classification
—
Expires
2020-10-21
Drug substance claim
No
Drug product claim
No
Assignee
Thales DIS France SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.